DarioHealth initiates strategic review after inquiries from interested parties

DarioHealth (DRIO) announced that its board of directors has initiated a strategic review following multiple unsolicited inbound strategic inquiries from interested parties. Dario’s board of directors has established a special committee of independent directors and engaged Perella Weinberg Partners as financial advisor. The special committee will consider a full range of potential opportunities including a sale, merger, strategic business combination, or continued execution of the company’s standalone strategy.